Back

Protease-activated receptor 2 (PAR2) inhibition reduces complement-associated cardiac remodelling in obesity-related heart failure

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Obesity and heart failure: what's new? Ventricular Remodelling ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Ms Emily Ghanbari

Berlin (Germany)

7 More presentations in this session

Presentation thumbnail
In-hospital economic impact and mortality of bariatric surgery on congestive heart failure in the USA: a nationwide analysis
Doctor S. Sinclair (Yankton, US)
Abstract Slides Video
Presentation thumbnail
What characterizes normotensive individuals with obesity and normal systolic heart function? A descriptive study from the SCAPIS cohort
Doctor J. Korduner (Lund, SE)
Abstract Slides Video
Presentation thumbnail
Effects of body mass index on worsening of heart failure and all-cause death in patients with heart failure and reduced left ventricular ejection fraction: a 10-year follow-up study
Mr M. Malmborg (Herlev, DK)
Abstract Slides Video
Presentation thumbnail
Association of epicardial adipose tissue with cardiac geometry alternation and diastolic dysfunction in the early stage of diabetic cardiomyopathy
Doctor J. Hsu (New Taipei City, TW)
Abstract Slides Video
Presentation thumbnail
Effect of empagliflozin on epicardial adipose tissue volume in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF)
Ms C. Turgut (Glasgow, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Obesity and heart failure: what's new?

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Temporal dynamics of cardiac remodelling in pressure overload: the key role of visceral adipose tissue
thumbnail
Congress Presentation
Genome-wide association study of clinical outcomes in heart failure and Mendelian randomisation analysis of the impact of elevated body mass index on disease progression
thumbnail
Congress Presentation
Protein expression profiles identify novel pathways associated with a high body mass index in patients with chronic heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources